Hypertrophic cardiomyopathy: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

• Individualized Exercise Training in Hypertrophic Cardiomyopathy

  NCT07835854· Oregon Health and Science University· Source

• A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

  NCT06112743· Bristol-Myers Squibb· Source

• Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions

  NCT07131371· Tampere University· Source

• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· Cytokinetics· Source

• A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

  NCT07004972· Bristol-Myers Squibb· Source

• Perfusion Abnormalities in Hypertrophic Cardiomyopathy

  NCT06599229· University of Virginia· Source

• A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

  NCT03723655· Bristol-Myers Squibb· Source

• A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

  NCT06253221· Bristol-Myers Squibb· Source

• Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

  NCT05648825· Xiang Wei· Source

• A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· Myokardia Inc.· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 5
• Organoids 1
• Mendelian Randomization Analysis 8
• CRISPR-Cas Systems 2
• Gene Expression Profiling 17
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 8
• Proteomics 6
• Metabolomics 2
• Immunohistochemistry 1
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 39
• Machine Learning 13
• Deep Learning 8
• Cohort Studies 25
• Genome-Wide Association Study 9

See which targets of this disease your abstract mentions, and go to the people working on them.